Susceptibility of extended-spectrum- -lactamase-producing Escherichia coli to commercially available and laboratory-isolated bacteriophages

被引：12
|
作者：
Fitzgerald-Hughes, Deirdre [1 ]
Bolkvadze, Darajen [2 ]
Balarjishvili, Nana [2 ]
Leshkasheli, Lika [2 ]
Ryan, Maia [2 ]
Burke, Liam [1 ]
Stevens, Niall [1 ]
Humphreys, Hilary [1 ,3 ]
Kutateladze, Mzia [2 ]
机构：
[1] Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Clin Microbiol, Dublin 9, Ireland
[2] G Eliava Inst Bacteriophages Microbiol & Virol, Lab Mol Biol, Tbilisi, Georgia
[3] Beaumont Hosp, Dept Microbiol, Dublin 9, Ireland
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2014年 / 69卷 / 04期
关键词：
Enterobacteriaceae; Ses phages; Enko phages; bacteriophage lysis; phylogenetic groups;
D O I：
10.1093/jac/dkt453
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1148 / 1150
页数：3
相关论文
共 50 条
  • [1] Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK
    Chislett, R. J.
    White, G.
    Hills, T.
    Turner, D. P. J.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 1076 - 1077
  • [2] Extended-Spectrum-β-Lactamase-Producing Escherichia coli as Intestinal Colonizers in the German Community
    Valenza, Giuseppe
    Nickel, Silke
    Pfeifer, Yvonne
    Eller, Christoph
    Krupa, Elzbieta
    Lehner-Reindl, Verena
    Hoeller, Christiane
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1228 - 1230
  • [3] Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread
    Suzuki, Satowa
    Shibata, Naohiro
    Yamane, Kunikazu
    Wachino, Jun-ichi
    Ito, Kenitiro
    Arakawa, Yoshichika
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (01) : 72 - 79
  • [4] Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-β-lactamase-producing Escherichia coli
    Krueger, Wolfgang A.
    Kempf, Volkhard A. J.
    Peiffer, Manou
    Nagele, Udo
    Unertl, Klaus E.
    Schroeder, Torsten H.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (02) : 817 - 820
  • [5] Multidirectional dynamic model for the spread of extended-spectrum-β-lactamase-producing Escherichia coli in the Netherlands
    Costa, Eduardo de Freitas
    Hagenaars, Thomas J.
    Dame-Korevaar, Anita
    Brouwer, Michael S. M.
    de Vos, Clazien J.
    [J]. MICROBIAL RISK ANALYSIS, 2022, 22
  • [6] Extended-spectrum β-lactamase-producing Escherichia coli
    Sloth, Louise B.
    Hargreaves, Sally
    Nellums, Laura B.
    Nielsen, Rikke T.
    Norredam, Marie
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 405 - 405
  • [7] Unacceptably High Error Rates in Vitek 2 Testing of Cefepime Susceptibility in Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Rhodes, Nathaniel J.
    Richardson, Chad L.
    Heraty, Ryan
    Liu, Jiajun
    Malczynski, Michael
    Qi, Chao
    Scheetz, Marc H.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3757 - 3761
  • [8] Molecular Characterization of Extended-Spectrum-β-Lactamase-Producing and Plasmid-Mediated AmpC β-Lactamase-Producing Escherichia coli Isolated from Stray Dogs in South Korea
    Tamang, Migma Dorji
    Nam, Hyang-Mi
    Jang, Geum-Chan
    Kim, Su-Ran
    Chae, Myung Hwa
    Jung, Suk-Chan
    Byun, Jae-Won
    Park, Yong Ho
    Lim, Suk-Kyung
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) : 2705 - 2712
  • [9] Duration of Stool Colonization in Healthy Medical Students with Extended-Spectrum-β-Lactamase-Producing Escherichia coli
    Li, Bin
    Zhong, Yang
    Fu, Xiao-chun
    Qiu, Yi-hui
    Wang, Si-Ying
    Yang, A-juan
    Huang, Xin-hong
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4558 - 4559
  • [10] Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
    Lee, Nan-Yao
    Lee, Ching-Chi
    Huang, Wei-Han
    Tsui, Ko-Chung
    Hsueh, Po-Ren
    Ko, Wen-Chien
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2888 - 2893
12345